When Gastric Cancer Vanishes Before Surgery: New Study Maps Who Beats the Odds
A large Chinese multicenter study finds that 16.4 percent of locally advanced gastric cancer patients achieve a pathological complete response ...
A large Chinese multicenter study finds that 16.4 percent of locally advanced gastric cancer patients achieve a pathological complete response ...
An integrated single-cell and spatial transcriptomic study has identified a triple-negative breast cancer-enriched malignant epithelial program, EP5, linked to aggressive ...
A Phase III trial of 807 patients found the trastuzumab biosimilar EG12014 statistically equivalent to reference trastuzumab in efficacy, safety, ...
A new review argues that neoadjuvant chemoradiotherapy may induce immune checkpoint blockade responsiveness in mismatch repair-proficient rectal cancer, with sequential ...
A new commentary warns that the three-factor risk model proposed for esophageal cancer patients achieving pathological complete response after neoadjuvant ...
A multicentre Phase II trial found that neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil before transoral surgery allowed 91 percent ...
Final Phase 3 IMpower030 results show that perioperative atezolizumab plus chemotherapy extended median event-free survival to 62.8 months versus 34.9 ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine